NCT07091799View on ClinicalTrials.gov

Interest of Measuring P2X4 Receptors on Blood Monocytes as a Diagnostic Marker in Amyotrophic Lateral Sclerosis: P2X4 as a Diagnostic Biomarker for ALS

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

March 31, 2027

Conditions
Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders
Interventions
DIAGNOSTIC_TEST

P2X4 receptors in blood samples

This is an interventional study designed to assay P2X4 receptors in blood samples from ALS patients and healthy volunteers by comparing the mean levels of P2X4 expression.

Trial Locations (1)

33000

Hôpital Pellegrin, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT07091799 - Interest of Measuring P2X4 Receptors on Blood Monocytes as a Diagnostic Marker in Amyotrophic Lateral Sclerosis: P2X4 as a Diagnostic Biomarker for ALS | Biotech Hunter | Biotech Hunter